Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Charting human cellular senescence in aging and disease.

Cell·2026
Same author

Characterization of the m<sup>6</sup>A Epitranscriptome in Fibroblast Senescence.

Molecular and cellular biology·2026
Same author

Sex-Related Differences in Circular RNA Expression in Multiple Sclerosis: A Pilot Study.

Journal of molecular neuroscience : MN·2026
Same author

Retraction: Modulation by miR-29b of intestinal epithelium homoeostasis through the repression of menin translation.

The Biochemical journal·2026
Same author

Correction: Post-transcriptional regulation of MEK-1 by polyamines through the RNA-binding protein HuR modulating intestinal epithelial apoptosis.

The Biochemical journal·2026
Same author

Age-Associated Impairment of Paneth Cells Driven by microRNA-152 Promotes Intestinal Epithelial Vulnerability to Pathological Stress.

Aging cell·2026

Related Experiment Video

Updated: May 25, 2026

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

Cancer surgery in the elderly.

Gopal C Kowdley1, Nishant Merchant, James P Richardson

  • 1Department of Surgery, Saint Agnes Hospital Center, 900 Caton Avenue, Baltimore, MD 21229, USA.

Thescientificworldjournal
|January 25, 2012
PubMed
Summary
This summary is machine-generated.

Physiologic age, not chronologic age, is crucial for cancer screening and treatment decisions in elderly patients. Individualized risk assessment using physiologic age helps optimize care and avoid ageism in oncogeriatrics.

Related Experiment Videos

Last Updated: May 25, 2026

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

Area of Science:

  • Gerontology
  • Oncology
  • Geriatric Medicine

Background:

  • Increasing global population of elderly individuals.
  • Rising incidence of cancer in the elderly population.
  • Need for age-sensitive approaches in cancer care.

Purpose of the Study:

  • To emphasize the importance of physiologic age over chronologic age in elderly cancer patients.
  • To advocate for individualized risk stratification in oncogeriatric care.
  • To highlight age-related physiological changes impacting surgical decisions.

Main Methods:

  • Utilizing tools to assess physiologic age.
  • Individualized risk stratification for cancer screening and treatment.
  • Evaluation of pre- and postoperative periods for surgical risk.

Main Results:

  • Physiologic age assessment aids in appropriate risk stratification.
  • Understanding age-related changes (impaired stress response, senescence, decreased immunity) is key.
  • Physiologic status influences the risk/benefit ratio of cancer surgery.

Conclusions:

  • Chronologic age should not be the sole determinant for cancer care in the elderly.
  • Assessing physiologic age is essential to combat ageism.
  • Individualized care based on physiologic age improves outcomes in oncogeriatric surgery.